UK markets closed

Evgen Pharma plc (EVG.L)

LSE - LSE Delayed price. Currency in GBp
Add to watchlist
13.38+1.00 (+8.08%)
At close: 5:07PM BST
Currency in GBp

Valuation measures

Market cap (intra-day) 518.36M
Enterprise value 313.61M
Trailing P/E N/A
Forward P/E 1N/A
PEG ratio (5-yr expected) 1N/A
Price/sales (ttm)N/A
Price/book (mrq)417.97
Enterprise value/revenue 3N/A
Enterprise value/EBITDA 6-4.33

Trading information

Stock price history

Beta (5Y monthly) 1.98
52-week change 3-8.55%
S&P500 52-week change 314.01%
52-week high 317.00
52-week low 32.50
50-day moving average 312.22
200-day moving average 311.41

Share statistics

Avg vol (3-month) 31.41M
Avg vol (10-day) 31.98M
Shares outstanding 5137.3M
Float 90.85M
% held by insiders 128.94%
% held by institutions 145.10%
Shares short 4N/A
Short ratio 4N/A
Short % of float 4N/A
Short % of shares outstanding 4N/A
Shares short (prior month ) 4N/A

Dividends & splits

Forward annual dividend rate 4N/A
Forward annual dividend yield 4N/A
Trailing annual dividend rate 3N/A
Trailing annual dividend yield 3N/A
5-year average dividend yield 4N/A
Payout ratio 40.00%
Dividend date 3N/A
Ex-dividend date 4N/A
Last split factor 2N/A
Last split date 3N/A

Financial highlights

Currency in GBP.

Fiscal year

Fiscal year ends 31 Mar 2020
Most-recent quarter (mrq)31 Mar 2020

Profitability

Profit margin 0.00%
Operating margin (ttm)0.00%

Management effectiveness

Return on assets (ttm)-51.93%
Return on equity (ttm)-86.46%

Income statement

Revenue (ttm)N/A
Revenue per share (ttm)N/A
Quarterly revenue growth (yoy)N/A
Gross profit (ttm)N/A
EBITDA -3.15M
Net income avi to common (ttm)-2.71M
Diluted EPS (ttm)-2.10
Quarterly earnings growth (yoy)N/A

Balance sheet

Total cash (mrq)4.13M
Total cash per share (mrq)0.03
Total debt (mrq)N/A
Total debt/equity (mrq)N/A
Current ratio (mrq)7.31
Book value per share (mrq)0.03

Cash flow statement

Operating cash flow (ttm)-2.58M
Levered free cash flow (ttm)-1.84M